Related Experiment Videos
Hypertension: trends, risks, drug therapies and clinical challenges in African Americans
Danielle Hollar1, Arthur S Agatston, Charles H Hennekens
1Agatston Research Institute, Miami Beach, Florida, USA. hollard@bellsouth.net
Insights
Cardiovascular disease (CVD) disproportionately affects African Americans. Effective hypertension drug therapies, including diuretics and calcium channel blockers, can significantly reduce stroke, heart disease, and cardiovascular death risks.
Area of Science:
- Public Health
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease (CVD) is the leading cause of death in the US, with hypertension as a major risk factor.
- Hypertension and its severe complications, including stroke and coronary heart disease (CHD), are more prevalent and severe in African Americans.
Purpose of the Study:
- To highlight the efficacy of antihypertensive drug therapies in reducing cardiovascular morbidity and mortality.
- To emphasize the need for effective strategies to increase the use of proven therapies among African Americans with hypertension.
Main Methods:
- Review of randomized trials and meta-analyses on hypertension drug therapy efficacy.
- Analysis of the impact of blood pressure reduction on stroke, CHD, and cardiovascular death rates.
Main Results:
- Antihypertensive drug therapy reduces blood pressure by 4-6 mm Hg, leading to significant decreases in stroke (35%-40%), CHD (20%-25%), and cardiovascular death (approx. 25%).
- Diuretics, ACE inhibitors, and beta-blockers are safe and effective, often used in combination.
- African Americans with hypertension may require multiple drug therapies, including diuretics and calcium channel blockers, due to disease severity.
Conclusions:
- Proven cardiovascular drug therapies are effective in managing hypertension and reducing adverse outcomes.
- Targeted strategies are needed to promote the widespread adoption of these beneficial therapies, particularly among African Americans, to decrease CVD mortality.
Abstract:
In the United States, cardiovascular disease (CVD) is the leading killer accounting for about 1 million fatalities annually, with hypertension being a major risk factor for stroke, coronary heart disease (CHD), cardiovascular (CV) death, heart failure, and end-stage renal disease--all of which have higher prevalence in African Americans, who also experience greater severity at clinical presentation. In numerous randomized trials and meta-analyses, drug therapy for hypertension has been shown to reduce blood pressure by 4-6 millimeters of mercury (mm Hg) with resultant decreases in stroke of 35%-40%, CHD of 20%-25%, and CV death of about 25%. Cardiovascular drug therapies of proven benefit, including diuretics, angiotensin converting enzyme (ACE inhibitors), and beta-blockers, are safe and effective, alone and in combination. Since African Americans with hypertension tend to have a more severe presentation, they will be even more likely to require multiple drug therapies, which also will include diuretics and calcium channel blockers. Effective strategies to encourage widespread use of these therapies of proven benefit would provide progress toward decreasing the adverse mortality experiences, especially CVD, among African Americans.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Drug Toxicity: Risk factors
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension I: Introduction